{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:58:38Z","timestamp":1770065918375,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.vaccine.2024.05.038","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:17:27Z","timestamp":1716491847000},"page":"125990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis"],"prefix":"10.1016","volume":"42","author":[{"given":"Ander","family":"Diez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Arrieta-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-7517","authenticated-orcid":false,"given":"Giulia","family":"Carrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-2487","authenticated-orcid":false,"given":"I\u00f1igo","family":"Fernandez-de-Larrinoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-8610","authenticated-orcid":false,"given":"Maria-Dolores","family":"Moragues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.038_b0005","series-title":"Candida and candidosis","author":"Odds","year":"1988"},{"key":"10.1016\/j.vaccine.2024.05.038_b0010","series-title":"Superficial candidosis: Fungal infection","author":"Richardson","year":"2003"},{"key":"10.1016\/j.vaccine.2024.05.038_b0015","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2024.05.038_b0020","doi-asserted-by":"crossref","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses [published correction appears in Clin Infect Dis. 2018 Aug 31;67(6):987]. Clin Infect Dis. 2017;64(2):134-140. doi:10.1093\/cid\/ciw691.","DOI":"10.1093\/cid\/ciw691"},{"key":"10.1016\/j.vaccine.2024.05.038_b0025","series-title":"Candida and candidiasis","author":"Calderone","year":"2012"},{"issue":"52","key":"10.1016\/j.vaccine.2024.05.038_b0030","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.038_b0035","doi-asserted-by":"crossref","unstructured":"Basile K, Halliday C, Kok J, Chen SC. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients. J Fungi (Basel). 2022;8(1):58. Published 2022 Jan 6. doi:10.3390\/jof8010058.","DOI":"10.3390\/jof8010058"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2024.05.038_b0040","first-page":"95","article-title":"Antibody and\/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?","volume":"36","author":"Casadevall","year":"1998","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.038_b0045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1615-9861(200104)1:4<550::AID-PROT550>3.0.CO;2-W","article-title":"Analysis of the serologic response to systemic Candida albicans infection in a murine model","volume":"1","author":"Pitarch","year":"2001","journal-title":"Proteomics"},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.038_b0050","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/IAI.70.10.5462-5470.2002","article-title":"Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine","volume":"70","author":"Bromuro","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.038_b0055","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/pmic.200400929","article-title":"Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine","volume":"4","author":"Fern\u00e1ndez-Arenas","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2024.05.038_b0060","doi-asserted-by":"crossref","unstructured":"Pitarch A, Nombela C, Gil C. La prote\u00f3mica, un nuevo reto para la microbiolog\u00eda cl\u00ednica [Proteomics, a new challenge for clinical microbiology] [published correction appears in Enferm Infecc Microbiol Clin. 2011 Mar;29(3):245]. Enferm Infecc Microbiol Clin. 2010;28(8):489-491. doi:10.1016\/j.eimc.2010.08.001.","DOI":"10.1016\/j.eimc.2010.08.001"},{"issue":"11","key":"10.1016\/j.vaccine.2024.05.038_b0065","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.1200594","article-title":"A novel Th cell epitope of Candida albicans mediates protection from fungal infection","volume":"188","author":"B\u00e4r","year":"2012","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.038_b0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vaccine.2015.11.035","article-title":"Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis","volume":"34","author":"Xin","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.038_b0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1128\/CMR.11.1.121","article-title":"Serologic response to cell wall mannoproteins and proteins of Candida albicans","volume":"11","author":"Martinez","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2024.05.038_b0080","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1128\/IAI.71.9.5273-5279.2003","article-title":"A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities","volume":"71","author":"Moragues","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.038_b0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1568005043341046","article-title":"Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapy","volume":"4","author":"Gozalbo","year":"2004","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.038_b0090","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/eji.200323790","article-title":"A role for antibodies in the generation of memory antifungal immunity","volume":"33","author":"Montagnoli","year":"2003","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.038_b0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0213-005X(04)73039-6","article-title":"Evaluaci\u00f3n de una nueva t\u00e9cnica comercializada (Candida albicans IFA IgG) para el diagn\u00f3stico de la candidiasis invasiva [Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis]","volume":"22","author":"Moragues","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"6","key":"10.1016\/j.vaccine.2024.05.038_b0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1469-0691.2009.02794.x","article-title":"Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients","volume":"15","author":"Zaragoza","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.05.038_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/721950","article-title":"Use of recombinant antigens for the diagnosis of invasive candidiasis","volume":"2008","author":"La\u00edn","year":"2008","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.038_b0110","first-page":"21","article-title":"Identification of superficial Candida albicans germ tube antigens in a rabbit model of disseminated candidiasis. a proteomic approach","volume":"17","author":"S\u00e1ez-Ros\u00f3n","year":"2014","journal-title":"Int Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.038_b0115","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind","volume":"66","author":"Edwards","year":"2018","journal-title":"Placebo-Controlled Trial Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.038_b0120","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3389\/fimmu.2018.01349","article-title":"Human Anti-Als3p antibodies are surrogate markers of NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis","volume":"9","author":"Uppuluri","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2024.05.038_b0125","doi-asserted-by":"crossref","first-page":"e1007460","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh","year":"2019","journal-title":"PLoS Pathog"},{"issue":"30","key":"10.1016\/j.vaccine.2024.05.038_b0130","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.038_b0135","doi-asserted-by":"crossref","unstructured":"Tarang S, Kesherwani V, LaTendresse B, Lindgren L, Rocha-Sanchez SM, Weston MD. In silico Design of a Multivalent Vaccine Against Candida albicans. Sci Rep. 2020;10(1):1066. Published 2020 Jan 23. doi:10.1038\/s41598-020-57906-x.","DOI":"10.1038\/s41598-020-57906-x"},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.038_b0140","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.038_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/403121","article-title":"Human monoclonal antibody-based therapy in the treatment of invasive candidiasis","volume":"2013","author":"Bugli","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2024.05.038_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114775","article-title":"Fungal infections: Immune defense, immunotherapies and vaccines","volume":"196","author":"Loh","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.038_b0155","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/jvi.55.3.836-839.1985","article-title":"Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide","volume":"55","author":"Emini","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.05.038_b0160","first-page":"45","article-title":"Prediction of the secondary structure of proteins from their amino acid sequence","volume":"47","author":"Chou","year":"1978","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"issue":"19","key":"10.1016\/j.vaccine.2024.05.038_b0165","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1021\/bi00367a013","article-title":"New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites","volume":"25","author":"Parker","year":"1986","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2024.05.038_b0170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"Kolaskar","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2024.05.038_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-7104-6_4","article-title":"Rational design of T lymphocyte epitope-based vaccines against coccidioides infection","volume":"1625","author":"Hurtgen","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.038_b0180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","article-title":"Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases","volume":"11","author":"Casadevall","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.vaccine.2024.05.038_b0185","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jprot.2010.02.008","article-title":"Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach","volume":"73","author":"Hern\u00e1ez","year":"2010","journal-title":"J Proteomics"},{"issue":"14","key":"10.1016\/j.vaccine.2024.05.038_b0190","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/pmic.201100588","article-title":"Cell surface shaving of Candida albicans biofilms, hyphae, and yeast form cells","volume":"12","author":"Vial\u00e1s","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2024.05.038_b0195","doi-asserted-by":"crossref","unstructured":"Backert L, Kohlbacher O. Immunoinformatics and epitope prediction in the age of genomic medicine. Genome Med. 2015;7:119. Published 2015 Nov 20. doi:10.1186\/s13073-015-0245-0.","DOI":"10.1186\/s13073-015-0245-0"},{"key":"10.1016\/j.vaccine.2024.05.038_b0200","doi-asserted-by":"crossref","unstructured":"Sesterhenn F, Yang C, Bonet J, et al. De novo protein design enables the precise induction of RSV-neutralizing antibodies. Science. 2020;368(6492):eaay5051. doi:10.1126\/science.aay5051.","DOI":"10.1126\/science.aay5051"},{"key":"10.1016\/j.vaccine.2024.05.038_b0205","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fimmu.2017.00224","article-title":"Linear epitopes of paracoccidioides brasiliensis and other fungal agents of human systemic mycoses as vaccine candidates","volume":"8","author":"Travassos","year":"2017","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.038_b0210","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nrmicro3156","article-title":"Development of vaccines for Candida albicans: fighting a skilled transformer","volume":"11","author":"Cassone","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2024.05.038_b0215","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.celrep.2018.10.042","article-title":"B cell receptor crosslinking augments germinal center B cell selection when T cell help is limiting","volume":"25","author":"Turner","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2024.05.038_b0220","unstructured":"Hermanson GT. Bioconjugate Techniques (3rd ed.). Elsevier Science. 2013."},{"key":"10.1016\/j.vaccine.2024.05.038_b0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biomaterials.2016.08.007","article-title":"An injectable, low-toxicity phospholipid-based phase separation gel that induces strong and persistent immune responses in mice","volume":"105","author":"Han","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.vaccine.2024.05.038_b0230","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/529204","article-title":"Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity","volume":"197","author":"Spellberg","year":"2008","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.038_b0235","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.038_b0240","doi-asserted-by":"crossref","first-page":"e25909","DOI":"10.1371\/journal.pone.0025909","article-title":"Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis","volume":"6","author":"Luo","year":"2011","journal-title":"PLoS One"},{"issue":"30","key":"10.1016\/j.vaccine.2024.05.038_b0245","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2021.06.001","article-title":"Synthetic conjugate peptide Fba-Met6 (MP12) induces complement-mediated resistance against disseminated Candida albicans","volume":"39","author":"Adams","year":"2021","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T06:08:24Z","timestamp":1723788504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0264410X24005978"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"125990"}}